HW English
News Report

The Race For Covid-19 Vaccine: Where Do Pfizer, Moderna and Oxford-AstraZeneca Stand?

Encouraging results on Covid-19 vaccine trials by frontrunners in November have raised hopes that a first generation of coronavirus antidotes is likely to receive approval as soon as December end or early 2021. Ongoing late-stage human trials of mRNA vaccine candidates developed by Pfizer-BioNTech and Moderna Inc have pointed to efficacy rates as high as 95 per cent, sowing hopes across the world in the battle against the pandemic that has claimed 1.34 million lives and upended economies everywhere.

#Pfizer #Moderna #CoronavirusVaccine #OxfordAstraZeneca

Related posts

Rajya Sabha Ruckus: opposition Unites, Boycott Session Until Suspended MPs Reinstated In House

News Desk

Nagaland becomes 3rd state to reject Citizenship (Amendment) Bill

Anil Rajpurohit

Why Modi’s leaders not taking Swachh Bharat seriously?

Anusha Bhattacharya